These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

91 related articles for article (PubMed ID: 1676055)

  • 21. Synthesis and dopaminergic features of six novel 3-arylpiperidines.
    Kostic-Rajacic A; Soskic V; Joksimovic J
    Boll Chim Farm; 1998 Nov; 137(10):417-21. PubMed ID: 10025971
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Identification of dopamine "D3" and "D4" binding sites, labelled with [3H]2-amino-6,7-dihydroxy-1,2,3,4-tetrahydronaphthalene, as high agonist affinity states of the D1 and D2 dopamine receptors, respectively.
    Urwyler S; Markstein R
    J Neurochem; 1986 Apr; 46(4):1058-67. PubMed ID: 2936868
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Dopamine D1 and D2 receptors are sensitive to the cationic form of apomorphine.
    Seeman P; Guan HC
    Mol Pharmacol; 1987 Dec; 32(6):760-3. PubMed ID: 2961976
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Effects of chronic treatment with selective agonists on the subtypes of dopamine receptors.
    Subramaniam S; Lucki I; McGonigle P
    Brain Res; 1992 Feb; 571(2):313-22. PubMed ID: 1351781
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Autoradiographic localization of D1 and D2 dopamine receptors in the human brain.
    De Keyser J; Claeys A; De Backer JP; Ebinger G; Roels F; Vauquelin G
    Neurosci Lett; 1988 Aug; 91(2):142-7. PubMed ID: 2972942
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Positron emission tomography (PET) study: the effects of 6R-L-erythro-5,6,7,8-tetrahydrobiopterin (R-THBP, SUN 0588) on the central dopamine D1, D2 and D3 receptors in rhesus monkey.
    Tani Y; Ishihara T; Kanai T; Ohno T; Onoe H; Watanabe Y; Andersson J; Lilija A; Westerberg G; Hartvig P
    Adv Exp Med Biol; 1993; 338():327-30. PubMed ID: 8304130
    [No Abstract]   [Full Text] [Related]  

  • 27. Effects of repeated injections of cocaine on catecholamine receptor binding sites, dopamine transporter binding sites and behavior in rhesus monkey.
    Farfel GM; Kleven MS; Woolverton WL; Seiden LS; Perry BD
    Brain Res; 1992 Apr; 578(1-2):235-43. PubMed ID: 1380862
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Distribution of D1 and D2 dopamine receptors in the basal ganglia of the cat determined by quantitative autoradiography.
    Beckstead RM; Wooten GF; Trugman JM
    J Comp Neurol; 1988 Feb; 268(1):131-45. PubMed ID: 2964456
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Dihydrexidine, a novel full efficacy D1 dopamine receptor agonist.
    Mottola DM; Brewster WK; Cook LL; Nichols DE; Mailman RB
    J Pharmacol Exp Ther; 1992 Jul; 262(1):383-93. PubMed ID: 1352553
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Cloning, expression, and comparison of the binding characteristics of the known human dopamine receptors.
    Hill P; Lai Y; Hnilo J; Lin CC; Karla M; Bounds S; Herz J; Mitchell R
    Adv Neurol; 1996; 69():41-52. PubMed ID: 8615159
    [No Abstract]   [Full Text] [Related]  

  • 31. New substituted 2-methylthiomethyl- and 2-methylsulphinylmethylenebenzimidazoles with D2/5-HT1A activity.
    Kostić-Rajacić S; Soskić V; Joksimović J
    Pharmazie; 1998 Jul; 53(7):438-41. PubMed ID: 9699220
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Identification and characterization of D1 and D2 dopamine receptors in cultured neuroblastoma and retinoblastoma clonal cell lines.
    Monsma FJ; Brassard DL; Sibley DR
    Brain Res; 1989 Jul; 492(1-2):314-24. PubMed ID: 2665904
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Dopamine D1 and D2 receptor selectivities of agonists and antagonists.
    Seeman P; Ulpian C
    Adv Exp Med Biol; 1988; 235():55-63. PubMed ID: 2976254
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Improvement in conditions for solubilisation and characterisation of brain D2 dopamine receptors using various detergents.
    Wheatley M; Hall JM; Frankham PA; Strange PG
    J Neurochem; 1984 Oct; 43(4):926-34. PubMed ID: 6470714
    [TBL] [Abstract][Full Text] [Related]  

  • 35. [3H]-quinelorane binds to D2 and D3 dopamine receptors in the rat brain.
    Gackenheimer SL; Schaus JM; Gehlert DR
    J Pharmacol Exp Ther; 1995 Sep; 274(3):1558-65. PubMed ID: 7562534
    [TBL] [Abstract][Full Text] [Related]  

  • 36. [The affinity of aromatic fluoride derivatives of phenothiazine neuroleptics to spiroperidol binding sites of dopamine receptors by the radioligand technic in vitro].
    Oelssner W; Peinhardt G; Büge A
    Pharmazie; 1985 May; 40(5):341-2. PubMed ID: 2863832
    [TBL] [Abstract][Full Text] [Related]  

  • 37. 6-hydroxydopamine treatments enhance behavioral responses to intracerebral microinjection of D1- and D2-dopamine agonists into nucleus accumbens and striatum without changing dopamine antagonist binding.
    Breese GR; Duncan GE; Napier TC; Bondy SC; Iorio LC; Mueller RA
    J Pharmacol Exp Ther; 1987 Jan; 240(1):167-76. PubMed ID: 3100767
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Pharmacological characterization of the D1- and D2-like dopamine receptors from the brain of the leopard frog, Rana pipiens.
    Chu J; Wilczynski W; Wilcox RE
    Brain Behav Evol; 2001 Jun; 57(6):328-42. PubMed ID: 11713387
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Striatal D1- and D2-dopamine receptor sites are separately detectable in vivo.
    Leslie CA; Bennett JP
    Brain Res; 1987 Jul; 415(1):90-7. PubMed ID: 2957025
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Effect of chronic nicotine treatment and withdrawal on rat striatal D1 and D2 dopamine receptors.
    Kirch DG; Taylor TR; Creese I; Xu SX; Wyatt RJ
    J Pharm Pharmacol; 1992 Feb; 44(2):89-92. PubMed ID: 1352822
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 5.